NewsBenzingaSeadrill hebt die Umsatzprognose für das Geschäftsjahr 2026 von 1,500 Mrd. USD–1,550 Mrd. USD auf 1,560 Mrd. USD–1,580 Mrd. USD an, gegenüber einer Schätzung von 1,548 Mrd. USD Seadrill hebt die Umsatzprognose für das Geschäftsjahr 2026 von 1,500 Mrd. USD–1,550 Mrd. USD auf 1,560 Mrd. USD–1,580 Mrd. USD an, gegenüber einer Schätzung von 1,548 Mrd. USD Benzinga 2026.11.03 21:19 (GMT+0) Open on Benzinga Other news Here's How Much $100 Invested In Royalty Pharma 10 Years Ago Would Be Worth Today CORRECTION: 3M Authorizes Additional $6B Stock Buyback, Bringing Total Share Repurchase Capacity To $7.5B 3M Reaches Broad Resolution Of AFFF Personal Injury Litigation; 3M Will Make A Pre-Tax $7.35B Nominal Commitment Over Nine Years, With A Present Value Of $5.8B UPDATE: Tarsus Pharmaceuticals Q3 Adj. EPS $(0.78) Beats $(2.73) Estimate, Sales $194.569M Beat $186.598M Estimate UPDATE: Precision BioSciences Q3 Adj. EPS $(0.74) Beats $(0.85) Estimate Hecla Mining Q3 EPS $0.22 Beats $0.16 Estimate, Sales $394.820M Beat $340.000M Estimate
CORRECTION: 3M Authorizes Additional $6B Stock Buyback, Bringing Total Share Repurchase Capacity To $7.5B
3M Reaches Broad Resolution Of AFFF Personal Injury Litigation; 3M Will Make A Pre-Tax $7.35B Nominal Commitment Over Nine Years, With A Present Value Of $5.8B
UPDATE: Tarsus Pharmaceuticals Q3 Adj. EPS $(0.78) Beats $(2.73) Estimate, Sales $194.569M Beat $186.598M Estimate
